Firebrick Pharma LimitedASX: FRE

Firebrick Investor Update Presentation

· Issued by Firebrick Pharma Limited via ASX

Filed with ASX ·

Firebrick Pharma Ltd | ABN 64 157 765 896 | L14, 333 Collins St. Melbourne, VIC, 3000, Australia P: 1300 301 874 | W: firebrickpharma.com 7 October 2026 ASX Announcement Firebrick Investor Update Presentation • Investor presentation with important details on the Company’s recently...

View Attachment

6ix hasn’t read this filing yet.

Firebrick Pharma Limited on 6ix

In the deck

Story so far

Earlier from Firebrick Pharma

Later from Firebrick Pharma

All Firebrick Pharma news releases